Hindustan Lever Limited v. Cavin Kare Limited And Ors.

In the high-stakes world of consumer products, patents are gold—but what protects that gold when a competitor quietly crosses the line? This case is a stark reminder that a promise made before a court is not a gentleman's agreement; it is a legal fortress. When that fortress is breached, the consequences can be swift and severe. For any founder relying on intellectual property, this story underscores a critical truth: the courtroom is not just where you fight—it's where you must keep your word.

Hindustan Lever Limited, a major player in the fast-moving consumer goods space, held Patent No. 169917, which covered a specific formulation involving a Silicone compound combined with particular ingredients used in fairness creams. The patent represented significant investment in research and development, and it gave Hindustan Lever exclusive rights to that formulation. At some point prior to this judgment, the parties had reached a compromise in which the respondents—Cavin Kare Limited and others—gave a formal undertaking recorded before the Court. That undertaking explicitly prohibited them from manufacturing and marketing a fairness cream using the patented Silicone compound combination. It was a clean, court-sanctioned boundary line.

Hindustan Lever alleged that Cavin Kare and the other respondents had willfully violated that recorded undertaking. The petitioner argued that despite the clear prohibition, the respondents continued to manufacture and market a fairness cream that used the very Silicone compound combination covered by the patent. This was not a fresh infringement claim—it was a contempt of court, because the respondents had already committed, on record, to stop. The respondents, on the other hand, pushed back. Conflicting reports were placed before the Court, with the respondents apparently disputing whether their product actually fell within the scope of the undertaking or the patent. The legal friction was sharp: was this a genuine misunderstanding of the formulation, or a calculated decision to test the limits of what the Court would tolerate?

After carefully weighing the conflicting reports and the evidence before it, the Court concluded that the breach was deliberate and wilful. The respondents had not stumbled into the violation—they had walked into it with eyes open. The Court found in favor of Hindustan Lever, treating the matter as a serious contempt of a court-recorded undertaking. The outcome reinforced that an undertaking given before the Court is not a mere formality; it is a binding commitment that can be enforced through contempt jurisdiction, which carries some of the most serious sanctions available in civil proceedings.

For founders, startup leaders, and IP professionals, the lesson is blunt: never treat a court-recorded undertaking as a soft commitment. If you sign one, assume the Court will hold you to every word, and assume your competitor will be watching your every product launch for any deviation. Before giving any undertaking, make absolutely certain you understand the full scope of what you are agreeing to—every ingredient, every formulation, every product line. And if you believe a competitor has breached such an undertaking, contempt jurisdiction can be a powerful and fast-moving tool, far more direct than a fresh infringement suit. In IP disputes, the strongest weapon is often not just your patent—it's the promise your opponent has already made under oath.